---
figid: PMC6154840__kmco-05-05-1190886-g001
figlink: /pmc/articles/PMC6154840/figure/f0001/
number: Figure 1
caption: PKCι drives both common and lineage-specific oncogenic pathways in lung cancer.
  In KRAS-driven lung adenocarcinoma (KRAS-driven LADC) PKCι acts as a critical downstream
  KRAS effector, activating a novel PKCι-ELF3-NOTCH3 signaling axis that establishes
  and maintains a KRAS-driven LADC TIC phenotype. In lung squamous cell carcinoma
  (LSCC) harboring 3q26 amplification, the 3q26 genes PRKCI, SOX2, and ECT2 are coordinately
  amplified and overexpressed, leading to lineage-specific activation of a PKCι-SOX2-HHAT
  signaling axis. This pathway drives a Hedgehog-dependent LSCC tumor-initiating cell
  (TIC) phenotype characterized by highly aggressive tumorigenic and invasive behavior
  and enhanced survival and chemoresistance. The PKCι gene target GLI1 is a major
  effector of this pathway. PKCι also activates a PKCι-ECT2-RAC1-MEK-ERK signaling
  pathway that drives transformed growth and invasion of both KRAS LADC and LSCC cells.
  The PKCι target matrix metalloproteinase 10 (MMP10) is a major effector of this
  pathway. The PKCι inhibitor auranofin exhibits antitumor activity against both LSCC
  and KRAS-driven LADC, and exhibits lineage-specific synergistic activity when combined
  with a NOTCH inhibitor in KRAS-driven LADC and a SMO inhibitor in LSCC.
pmcid: PMC6154840
papertitle: 'Protein kinase Cι: A versatile oncogene in the lung.'
reftext: Alan P. Fields, et al. Mol Cell Oncol. 2018;5(5):e1190886.
pmc_ranked_result_index: '16251'
pathway_score: 0.9518769
filename: kmco-05-05-1190886-g001.jpg
figtitle: PKCι drives both common and lineage-specific oncogenic pathways in lung
  cancer
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6154840__kmco-05-05-1190886-g001.html
  '@type': Dataset
  description: PKCι drives both common and lineage-specific oncogenic pathways in
    lung cancer. In KRAS-driven lung adenocarcinoma (KRAS-driven LADC) PKCι acts as
    a critical downstream KRAS effector, activating a novel PKCι-ELF3-NOTCH3 signaling
    axis that establishes and maintains a KRAS-driven LADC TIC phenotype. In lung
    squamous cell carcinoma (LSCC) harboring 3q26 amplification, the 3q26 genes PRKCI,
    SOX2, and ECT2 are coordinately amplified and overexpressed, leading to lineage-specific
    activation of a PKCι-SOX2-HHAT signaling axis. This pathway drives a Hedgehog-dependent
    LSCC tumor-initiating cell (TIC) phenotype characterized by highly aggressive
    tumorigenic and invasive behavior and enhanced survival and chemoresistance. The
    PKCι gene target GLI1 is a major effector of this pathway. PKCι also activates
    a PKCι-ECT2-RAC1-MEK-ERK signaling pathway that drives transformed growth and
    invasion of both KRAS LADC and LSCC cells. The PKCι target matrix metalloproteinase
    10 (MMP10) is a major effector of this pathway. The PKCι inhibitor auranofin exhibits
    antitumor activity against both LSCC and KRAS-driven LADC, and exhibits lineage-specific
    synergistic activity when combined with a NOTCH inhibitor in KRAS-driven LADC
    and a SMO inhibitor in LSCC.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PAK1
  - MAPK1
  - MAPK3
  - CSHL1
  - ECT2
  - ELF3
  - NOTCH4
  - NOTCH3
  - PARD6A
  - PRKD3
  - PRKCA
  - MMP10
  - NOTCH2
  - NOTCH1
  - PRKCI
  - PRKCQ
  - HES5
  - GLI1
  - HES2
  - HES1
  - HES7
  - MAP2K1
  - MAP2K2
  - HES4
  - PRKCH
  - HHAT
  - KRAS
  - PRKCG
  - RAC1
  - SHH
  - PRKCZ
  - PTCH1
  - SUFU
  - PRKCB
  - HES3
  - HES6
  - SOX2
  - PRKCD
  - PRKCE
  - SMO
  - Auranofin
  - Squamous Cell Carcinoma
genes:
- word: PAK1
  symbol: PAK1
  source: hgnc_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CSL/
  symbol: CSL
  source: hgnc_alias_symbol
  hgnc_symbol: CSHL1
  entrez: '1444'
- word: ECT2
  symbol: ECT2
  source: hgnc_symbol
  hgnc_symbol: ECT2
  entrez: '1894'
- word: ELF3
  symbol: ELF3
  source: hgnc_symbol
  hgnc_symbol: ELF3
  entrez: '1999'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: NOTCH3
  symbol: NOTCH3
  source: hgnc_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: PAR6
  symbol: PAR-6
  source: hgnc_alias_symbol
  hgnc_symbol: PARD6A
  entrez: '50855'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: MMP-10
  symbol: MMP10
  source: hgnc_symbol
  hgnc_symbol: MMP10
  entrez: '4319'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES5
  entrez: '388585'
- word: GLI1
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES2
  entrez: '54626'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES1
  entrez: '3280'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES7
  entrez: '84667'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES4
  entrez: '57801'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: HHAT
  symbol: HHAT
  source: hgnc_symbol
  hgnc_symbol: HHAT
  entrez: '55733'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: RAC1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: SHH
  symbol: SHH
  source: hgnc_symbol
  hgnc_symbol: SHH
  entrez: '6469'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PTCH1
  symbol: PTCH1
  source: hgnc_symbol
  hgnc_symbol: PTCH1
  entrez: '5727'
- word: SuFu
  symbol: SUFU
  source: hgnc_symbol
  hgnc_symbol: SUFU
  entrez: '51684'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES3
  entrez: '390992'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES6
  entrez: '55502'
- word: Sox2
  symbol: SOX2
  source: hgnc_symbol
  hgnc_symbol: SOX2
  entrez: '6657'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: SMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
chemicals:
- word: Auranofin
  source: MESH
  identifier: D001310
diseases:
- word: Squamous Cell Carcinoma
  source: MESH
  identifier: D002294
---
